| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |